Envoy Medical Statistics
Total Valuation
Envoy Medical has a market cap or net worth of $43.32 million. The enterprise value is $43.73 million.
| Market Cap | 43.32M |
| Enterprise Value | 43.73M |
Important Dates
The next estimated earnings date is Friday, August 16, 2024, before market open.
| Earnings Date | Aug 16, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Envoy Medical has 19.60 million shares outstanding. The number of shares has increased by 93.63% in one year.
| Shares Outstanding | 19.60M |
| Shares Change (YoY) | +93.63% |
| Shares Change (QoQ) | +56.14% |
| Owned by Insiders (%) | 63.86% |
| Owned by Institutions (%) | 16.25% |
| Float | 6.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 145.85 |
| Forward PS | 99.92 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 147.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.11
| Current Ratio | 1.11 |
| Quick Ratio | 0.74 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -638.92 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -235.80% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $8,735 |
| Profits Per Employee | -$692,265 |
| Employee Count | 34 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -78.42% in the last 52 weeks. The beta is 1.24, so Envoy Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.24 |
| 52-Week Price Change | -78.42% |
| 50-Day Moving Average | 3.09 |
| 200-Day Moving Average | 3.22 |
| Relative Strength Index (RSI) | 38.71 |
| Average Volume (20 Days) | 24,055 |
Short Selling Information
The latest short interest is 30,565, so 0.16% of the outstanding shares have been sold short.
| Short Interest | 30,565 |
| Short Previous Month | 14,832 |
| Short % of Shares Out | 0.16% |
| Short % of Float | 0.44% |
| Short Ratio (days to cover) | 0.19 |
Income Statement
In the last 12 months, Envoy Medical had revenue of $297,000 and -$23.54 million in losses. Loss per share was -$0.21.
| Revenue | 297,000 |
| Gross Profit | -612,000 |
| Operating Income | -19.50M |
| Pretax Income | -23.04M |
| Net Income | -23.54M |
| EBITDA | -22.83M |
| EBIT | -23.00M |
| Loss Per Share | -$0.21 |
Balance Sheet
The company has $4.95 million in cash and $5.36 million in debt, giving a net cash position of -$411,000 or -$0.02 per share.
| Cash & Cash Equivalents | 4.95M |
| Total Debt | 5.36M |
| Net Cash | -411,000 |
| Net Cash Per Share | -$0.02 |
| Equity (Book Value) | -7.41M |
| Book Value Per Share | -0.38 |
| Working Capital | 734,000 |
Cash Flow
In the last 12 months, operating cash flow was -$21.32 million and capital expenditures -$262,000, giving a free cash flow of -$21.58 million.
| Operating Cash Flow | -21.32M |
| Capital Expenditures | -262,000 |
| Free Cash Flow | -21.58M |
| FCF Per Share | -$1.10 |
Margins
Gross margin is -206.06%, with operating and profit margins of -6,564.98% and -7,924.92%.
| Gross Margin | -206.06% |
| Operating Margin | -6,564.98% |
| Pretax Margin | -7,756.57% |
| Profit Margin | -7,924.92% |
| EBITDA Margin | -7,688.22% |
| EBIT Margin | -7,744.44% |
| FCF Margin | -7,266.81% |
Dividends & Yields
Envoy Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -93.63% |
| Shareholder Yield | -93.63% |
| Earnings Yield | -54.34% |
| FCF Yield | -49.83% |
Analyst Forecast
The average price target for Envoy Medical is $7.25, which is 228.05% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.25 |
| Price Target Difference | 228.05% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Envoy Medical has an Altman Z-Score of -50.91 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -50.91 |
| Piotroski F-Score | 3 |